Trinity Biotech PLC (TRIB)
1.66
+0.01
(+0.61%)
USD |
NASDAQ |
May 10, 16:00
1.66
0.00 (0.00%)
After-Hours: 19:30
Trinity Biotech Cash from Financing (TTM): -16.04M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -16.04M |
| September 30, 2023 | -15.68M |
| June 30, 2023 | -15.62M |
| March 31, 2023 | 2.158M |
| December 31, 2022 | -12.32M |
| September 30, 2022 | -14.51M |
| June 30, 2022 | -12.86M |
| March 31, 2022 | -20.66M |
| December 31, 2021 | -6.019M |
| September 30, 2021 | -7.67M |
| June 30, 2021 | -6.944M |
| March 31, 2021 | -0.162M |
| December 31, 2020 | -2.716M |
| September 30, 2020 | -3.009M |
| June 30, 2020 | -1.494M |
| March 31, 2020 | -7.561M |
| December 31, 2019 | -7.529M |
| September 30, 2019 | -6.394M |
| June 30, 2019 | -19.95M |
| March 31, 2019 | -17.20M |
| December 31, 2018 | -16.87M |
| September 30, 2018 | -14.47M |
| June 30, 2018 | -4.22M |
| March 31, 2018 | -10.34M |
| December 31, 2017 | -12.64M |
| Date | Value |
|---|---|
| September 30, 2017 | -15.68M |
| June 30, 2017 | -13.89M |
| March 31, 2017 | -14.76M |
| December 31, 2016 | -13.36M |
| September 30, 2016 | -6.281M |
| June 30, 2016 | -11.54M |
| March 31, 2016 | 106.19M |
| December 31, 2015 | 107.52M |
| September 30, 2015 | 109.08M |
| June 30, 2015 | 109.30M |
| March 31, 2015 | -0.377M |
| December 31, 2014 | -1.427M |
| September 30, 2014 | -1.455M |
| June 30, 2014 | 3.575M |
| March 31, 2014 | -1.848M |
| December 31, 2013 | -0.798M |
| September 30, 2013 | -3.246M |
| June 30, 2013 | -4.315M |
| March 31, 2013 | -5.182M |
| December 31, 2012 | -6.193M |
| September 30, 2012 | -8.345M |
| June 30, 2012 | -10.28M |
| March 31, 2012 | -7.188M |
| December 31, 2011 | -7.247M |
| September 30, 2011 | -4.65M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-20.66M
Minimum
Mar 2022
2.158M
Maximum
Mar 2023
-9.210M
Average
-7.561M
Median
Mar 2020
Cash from Financing (TTM) Benchmarks
| Avadel Pharmaceuticals PLC | 135.34M |
| Amarin Corp PLC | -1.56M |
| DBV Technologies SA | 6.767M |
| Adaptimmune Therapeutics PLC | 0.88M |
| Akari Therapeutics PLC | -- |